Upload
mrs-rehan
View
213
Download
0
Embed Size (px)
Citation preview
7/29/2019 Challenges Associated With Prolonged Survival of Patients With Thalassemia
1/6
DOI: 10.1542/peds.2007-19442008;121;e1426Pediatrics
Khaled Musallam, Maria D. Cappellini and Ali Taher
Transitioning From Childhood to AdulthoodChallenges Associated With Prolonged Survival of Patients With Thalassemia:
http://pediatrics.aappublications.org/content/121/5/e1426.full.html
located on the World Wide Web at:The online version of this article, along with updated information and services, is
of Pediatrics. All rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.Boulevard, Elk Grove Village, Illinois, 60007. Copyright 2008 by the American Academypublished, and trademarked by the American Academy of Pediatrics, 141 Northwest Point
publication, it has been published continuously since 1948. PEDIATRICS is owned,PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
at Pakistan:AAP Sponsored on February 7, 2013pediatrics.aappublications.orgDownloaded from
https://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.htmlhttps://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.htmlhttps://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.htmlhttps://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.html7/29/2019 Challenges Associated With Prolonged Survival of Patients With Thalassemia
2/6
SPECIAL ARTICLE
Challenges Associated With Prolonged Survival of
Patients With Thalassemia: Transitioning FromChildhood to Adulthood
KhaledMusallam, BSca, MariaD. Cappellini, MDb, Ali Taher,MDc
aFaculty of Medicine and cDepartment of Internal Medicine, Hematology-Oncology Division, American University of Beirut Medical Center, Beirut, Lebanon; bDepartment
of Internal Medicine, University of Milan, Milan, Italy
The authors have indicated they have no financial relationships relevant to this article to disclose.
ABSTRACT
Thalassemia is a chronic condition that presents a range of clinical and psychosocial
challenges. Although recent advances in the treatment of thalassemia can prolong
patient life spans, problems may arise when patients are transferred from pediatric
health care settings to adult health care settings. These issues and our recommen-
dations for handling them are discussed.
OVER THE PAST few decades, medicine has seen the clinical evolution of thalas-semia major, an inherited disorder of blood hemoglobin. When thalassemia
was first described, the prognosis for patients was poor because the condition was
incompatible with life. However, as research into this debilitating disease progressed,
it was discovered that continuous blood transfusions enabled patients to survive for
up to 1 decade, until complications associated with iron toxicity from the ongoing
transfusions led to death. Subsequent breakthroughs in iron chelation therapy, withdeferoxamine and deferiprone, meant that patients with thalassemia could have a
normal life span, provided they received regular transfusions and iron chelation
therapy. However, because patients face the burden of a chronic illness, psychosocial issues can be a significant
impediment to compliance with ongoing therapy. One of the primary challenges these patients encounter is adjusting
to the transition from a pediatric health care system to an adult health care system.Because of the nature of the poor prognosis, in the early days of treatment thalassemia was regarded as a condition
of the young and was treated by pediatric teams. However, improvements in therapy and the availability of effectiveiron chelation regimens mean that patients can be expected to survive beyond adolescence, and adults now
constitute 44% of the thalassemic population in the United States.1 Whereas in the past most children with special
health care needs died before reaching adulthood, now 90% of the 500 000 children who transition intoadulthood each year in the United States survive.2,3 This report discusses the clinical and psychosocial effects of
thalassemia as patients move from the pediatric age group to adulthood and suggests possible ways to ease this
important transition.
CLINICALPERSPECTIVE
Thalassemia is a significant issue for medical centers throughout the world, because they must not only accommodate
the constant demand for blood transfusions but also support the need for self-administered iron chelation therapy.
Unfortunately, many centers remain focused primarily on the care of pediatric patients. If adult patients need to
receive their treatment at such a center, then the staff members are faced with a number of challenges. For example,equipment at these thalassemia centers is designed primarily for pediatric patients. Also, nurses and maintenance
staff members generally are accustomed to dealing with children and may not be familiar with adult-specific issues.1
For example, adult patients with thalassemia experience a spectrum of clinical complications not seen in pediatric
patients, such as osteoporosis, cardiac disease, organ failure, and pain, which require the attention of specialists not
commonly found in the pediatric setting.1 If adult patients with thalassemia choose to move from thalassemia centersto adult health care facilities, such as standard hospitals, then they face another problem because of the lack of
thalassemia specialists proficient in managing their condition. The ideal solution would be to establish efficient
communication between the medical committees at the 2 institutions. High-quality relationships and constant
communication between health care providers seem to have a significant positive effect on the management of any
chronic illness, especially when the illness requires such transitions. 4
Compliance with treatment is the most important factor in ensuring the desired outcome for patients with
thalassemia. However, psychosocial issues may negatively influence compliance, an effect that may differ signifi-
cantly between children and adults. Although iron chelation therapy has been available for many years, the
burdensome regimen of subcutaneous deferoxamine infusions can have a significant impact and affect compliance
www.pediatrics.org/cgi/doi/10.1542/
peds.2007-1944
doi:10.1542/peds.2007-1944
Key Words
health care transition, psychosocial,
thalassemia
Accepted for publication Nov 12, 2007
Address correspondence to Ali Taher, MD,
Department of Internal Medicine, American
University of Beirut Medical Center, PO Box
11-0236, Riad El Solh 1107 2020, Beirut,
Lebanon. E-mail: [email protected]
PEDIATRICS (ISSNNumbers:Print, 0031-4005;
Online, 1098-4275). Copyright 2008by the
AmericanAcademy of Pediatrics
e1426 MUSALLAM et alat Pakistan:AAP Sponsored on February 7, 2013pediatrics.aappublications.orgDownloaded from
https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+7/29/2019 Challenges Associated With Prolonged Survival of Patients With Thalassemia
3/6
with treatment. The recent emergence of oral iron che-
lation therapy (with deferiprone) has helped lessen the
burden of deferoxamine infusions and thus is improving
compliance.5 If we, as treating physicians, educate our
patients about the ongoing research aimed toward im-
proving thalassemia care, we may give them the incen-
tive to abide by current treatment plans and to look
forward to future advances in treatment modalities.
PSYCHOSOCIAL PERSPECTIVE
Factors in Maturation
Regardless of gender, culture, religion, and socioeco-
nomic status, the process of physical aging is accompa-
nied by a psychological maturation that is reflected in an
individuals interpretation of self, existence, and inter-
personal relationships. Any experience spanning an in-
dividuals lifetime, such as living with a chronic disease,
will inevitably affect his or her psychological develop-
ment. Both the natural course of the disease and any
interventions should always be taken into considerationin this regard. To do this effectively, one must identify
the impact the disease and treatment may have on all
facets of the patients life. As far as patients with thalas-
semia are concerned, the following areas differ substan-
tially in terms of the impact on pediatric and adult pa-
tient populations and therefore require special attention
from health care providers and adult thalassemia care
facilities.
Maturity and Education
Children with thalassemia usually are not aware of the
gravity of their disease but, as they mature, they become
more aware of the nature of thalassemia, either by their
own accord or through their health care provider. This
realization may create a level of denial and cause dis-
tress, but we cannot deny childrens rights to knowledge
regarding their own physical state. To overcome this,
parents and physicians must be aware of an age-appro-
priate approach to disease education. They should con-
sider the level of the patients education and their psy-
chological maturity before gradually discussing the
reality of thalassemia as a disease. An age-appropriate
approach might be to start with cartoon illustrations for
children and eventually provide detailed scientific infor-
mation supplemented by articles for young adults. The
patients may then accept the seriousness of their diseaseand, it is hoped, be fully compliant with treatment.
The use of an adult psychologist may be helpful in
providing a link between patients, school officials, the
family, and the physician. It must kept in mind that,
throughout the early course of the disease and its man-
agement, absenteeism from school and a lack of energy
when performing academic duties may affect the educa-
tion of the patient. Because of these issues, patients with
thalassemia may find their future compromised. Psy-
chologists may assist in alleviating these burdens and
improve the chances of patients succeeding throughout
their academic paths and future careers.
Independence
Aiming for an independent lifestyle, both physically andemotionally, usually begins at adolescence. Psychologi-
cal separation and growth of self throughout adoles-
cence are essential for the normal process of maturation
of an individual. It is at this time of life that an individual
begins to question the meanings of birth, existence, anddeath and the nature of causality. For patients with
thalassemia, 2 main problems may arise. First, the ado-lescent patient has already been affected by a chronic
illness. Overprotective, negligent, or hostile parents, un-
compassionate peers and society, the burden of diseasecomplications, blood transfusions, and iron chelation
pumps all may contribute to a negative view of the
world. Second, these views may be accompanied by
feelings of fear, shame, and denial. All of these can be
lessened through appropriate attention and guidance;this is why the roles of the parents and psychologist are
fundamental early in childhood, to provide a normal
atmosphere as the child develops, by giving support and
direction. Without this, the development of the adult
may be affected.When adolescents with thalassemia embark on a new
journey to become independent from their parents, they
are faced not only with the burden of a psyche affected
by chronic illness but also with additional serious re-
sponsibilities, compared with their healthy peers. Themanagement of their condition requires much attention
and planning, which previously might have been man-
aged by their parents. For this reason, parents and phy-
sicians should involve patients with thalassemia in their
own treatment plans, to create eventually self-sufficientadolescents. The patients should be taught to be respon-
sible for their own regular appointments with thalasse-
mia clinical and psychosocial specialists, blood transfu-sions and iron chelation sessions, and finances. It is the
latter that may present the biggest problem, because it isundeniable that thalassemia treatment is costly. With
time, adults with thalassemia will need to bear the
weight of other financial responsibilities and the regular
costs of treatment, which may worsen the situation. As
discussed, adults with thalassemia may need to switch toan adult health care system where treatment is much
more expensive than that provided at the thalassemia
centers. Adolescent patients should be made aware of
these future problems and ideally should be provided
with some assistance (either governmental or through
medical insurance companies).
Work
According to the study by Laurice,1 adult patients with
thalassemia spend an average of 271 hours per monthon care (including blood transfusions, deferoxamine
therapy, doctor appointments, taking medications, med-
ically related telephone calls, and travel time). Conse-
quently, the chosen career path for a patient with thalas-
semia should be selected with consideration of thefinancial cost, the patients physical capabilities, and
the time-consuming nature of this disease. Once again,
the role of the psychologist in the choice of a career path is
important. Communication between health care providers
PEDIATRICS Volume 121, Number 5, May 2008 e1427at Pakistan:AAP Sponsored on February 7, 2013pediatrics.aappublications.orgDownloaded from
https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+7/29/2019 Challenges Associated With Prolonged Survival of Patients With Thalassemia
4/6
and employers would be beneficial for creating a better
working environment without interfering with the pa-
tients positive attitude toward normality.
Interpersonal Relationships
The way in which patients with a chronic illness interactwith others is often determined by their childhood and
development. As children, patients with thalassemia
might have felt the need to hide their disease from their
peers out of shame of being different or not accepted by
society (some children or adults may be so misinformedas to think the disease is infectious). The course of the
disease and management also might have prevented thechildren from having enough time or energy to engage
in play with their peers. Conversely, the patients might
have felt comfortable enough to share their disease sta-
tus with their friends and, in turn, developed muchmore healthy relationships. Psychologists should be
aware of the fact that encouraging healthy peer relation-
ships for young patients with thalassemia is important
not only for improving compliance (because the patient
then may not attempt to evade treatment to feel morenormal) but also for developing their future ability to
engage in healthy relationships as adults and for easing
much of the psychological trauma of thalassemia. Moti-
vating self-acceptance and confidence in relationships
may build a solid foundation for the patients. It is alsoworth noting that patients with thalassemia may be
more likely to engage in drug abuse, smoking, and alco-
hol drinking as a means to fit into society or to escape
their condition.
Marriage
Before recent advancements in thalassemia treatment,
the concept of marriage and family was inconceivable topatients with thalassemia. As treatment has improved
and patient survival has lengthened, living long enough
to marry and to have children is now a real possibility.
However, this may be affected by the natural course of
the disease and inherent complications, because some
abnormalities in sexual differentiation may occur. Be-
cause this can severely affect the physical and emotionalrelationships of adults with thalassemia with members of
the opposite gender, it requires extensive counseling
from an adult psychologist, especially as affected patients
enter new romantic relationships. Moreover, alternative
approaches to pregnancy should be discussed with thepatient if natural conception is not possible.
Psychiatric Disorders
In the biopsychosocial model describing the pathogene-
sis of psychiatric conditions, the development of psychi-atric disorders is related to the impact of the following
sequence of events: genetic predisposition, early life
events, and current stressful life events.6 It can be seenclearly that thalassemia could affect the latter 2 factors.
This means that the chances of patients with thalassemia
developing serious psychiatric conditions or mood disor-
ders, beyond the anxiety, guilt, shame, or depression
that may accompany any normal stressful situation, are
increased. Therefore, careful monitoring and any neces-sary referrals to a psychiatrist by the specialized adult
psychologist are recommended.
CONCLUSIONS
In light of the clinical and psychosocial difficulties in
shifting from a pediatric health care system to an adult
health care system we have discussed here, the following
modifications to thalassemia management could be ben-eficial. First, modification of the health care system to
provide necessary medical attention for adult patients
with thalassemia could be achieved by employing more
thalassemia specialists and adult psychologists at health
care facilities or by improving thalassemia pediatric cen-ters to include facilities equipped for proper handling of
adult medical and psychosocial issues. Well-organized
communication between the 2 systems is also suggested.
A patient-centered, flexible, responsive, comprehensive,
TABLE 1 Thalassemia Pediatric to Adult Health Care Transition
Domain Challenge Recommendations
Clinical
Setting Hardware Modification of equipment
Staff Lack of adult specialists and adult psychologists in pediatric
thalassemia centers
Employment of missing staff members
Lack of thalassemia specialists in adult health care centers Employment of missing staff members
Authorities Lack of insight regarding health care transit ion problems Provision of funding and policies
Research Lack of studies about the extent to which adolescents are receiving
health care transition services
More research about psychosocial aspects and enhancement
of treatment modalities to improve compliance
Psychosocial
Education Increased awareness regarding the nature of the disease Psychosocial management
Independence Physical Financial and directive support
Psychological Psychosocial management
Work Absenteeism because of occupancy with management or lack
of energy
Psychosocial management
Relationships Limited because of lack of energy, occupancy, shame, nonacceptance,
or denial
Psychosocial management
Marriage Financial, sexual, and emotional burdens Psychosocial management
Psychiatric disorders Increased vulnerability Psychosocial management
e1428 MUSALLAM et alat Pakistan:AAP Sponsored on February 7, 2013pediatrics.aappublications.orgDownloaded from
https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+7/29/2019 Challenges Associated With Prolonged Survival of Patients With Thalassemia
5/6
well-coordinated transition should be the primary tar-
get.6 In fact, many attempts are made each day to de-
velop policies aimed at achieving the desired outcome
for thalassemia treatment transitions. One example is
the consensus statement on health care transitions for
young adults with special health care needs, whose goals
are to ensure that physicians who provide primary or
subspecialty care to young people with special health
care needs (1) understand the rationale for transition
from child-oriented to adult-oriented health care; (2)
have the knowledge and skills to facilitate that process;
and (3) know if, how, and when transfer of care is
indicated.7
Second, a practical approach to ensure adequate psy-
chological management is to consider scheduling regular
appointments (every 3 or 6 months) with an adult psy-
chologist who is informed by the thalassemia specialist
about the specific needs of the patient. Funding boards
should include the expenses of such visits in the assigned
aid for patients. The psychologists main role is to help
patients and parents discuss and express their feelings
about the illness, to help patients accept the illness andtake care of themselves, to facilitate a normal lifestyle,
and to support full control of the various issues men-
tioned in this report.
Third, competent primary care providers should be
open-minded about the psychological aspects of having
and treating an inherited disease and should be available
to accompany and to support patients throughout their
development. The organizational structure of the health
care facility should be well prepared for the latter. If
experienced specialists always rotate to different wards,
then they will not be able to monitor the developmental
well-being of patients. Proper scheduling is necessary to
ensure that patients are treated by the same specialisteach time.
Fourth, more research should focus on the needs of
patients with thalassemia who are transferring from pe-
diatric to adult care. Determining the extent to which
adolescents are receiving health care transition servicesand understanding the main factors influencing the ad-
equacy of such services are important gaps in current
research.4 Controlled studies that involve patients and
their families may provide convincing data, encouraging
authorities to become involved in funding the process ofservice modification, recruiting the appropriate person-
nel, and providing adequate medical insurance. Qualita-tive and quantitative studies should be the main focus of
health care societies in searching for ideal health care for
thalassemia8,9 (Table 1).
REFERENCES
1. Laurice M. Caring for adult thalassemics in a pediatric world.
Presented at the Cooleys Anemia Eighth Symposium, Lake
Buena Vista, FL; March 1719, 2005
2. Newacheck PW, Taylor WR. Childhood chronic illness: preva-
lence, severity, and impact. Am J Public Health. 1992;82(3):
364371
3. Blum RW. Transition to adult health care: setting the stage. J
Adolesc Health. 1995;17(1):35
4. Scal P, Ireland M. Addressing transition to adult health care foradolescents with special health care needs. Pediatrics. 2005;
115(6):16071612
5. Zahed L, Mourad FH, Alameddine R, Aoun S, Koussa S, Taher
A. Effect of oral iron chelation therapy with deferiprone (L1) on
the psychosocial status of thalassemia patients. Haematologia.
2002;31(4):333339
6. American Psychiatric Association. Diagnostic and Statistical Man-
ual of Mental Disorders. 4th ed. Washington, DC: American Psy-
chiatric Association; 2000
7. American Academy of Pediatrics, American Academy of Family
Physicians, American College of Physicians, American Society of
Internal Medicine. A consensus statement on health care tran-
sitions for young adults with special health care needs. Pediatrics.
2002;110(6):13041306
8. Galanello R. A thalassemic child becomes adult. Rev Clin Exp
Hematol. 2003;7(1):421
9. Reiss J, Gibson R. Health care transition: destination unknown.
Pediatrics. 2002;110(6):13071314
PEDIATRICS Volume 121, Number 5, May 2008 e1429at Pakistan:AAP Sponsored on February 7, 2013pediatrics.aappublications.orgDownloaded from
https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+7/29/2019 Challenges Associated With Prolonged Survival of Patients With Thalassemia
6/6
DOI: 10.1542/peds.2007-1944
2008;121;e1426PediatricsKhaled Musallam, Maria D. Cappellini and Ali Taher
Transitioning From Childhood to AdulthoodChallenges Associated With Prolonged Survival of Patients With Thalassemia:
ServicesUpdated Information &
htmlhttp://pediatrics.aappublications.org/content/121/5/e1426.full.including high resolution figures, can be found at:
References
html#ref-list-1http://pediatrics.aappublications.org/content/121/5/e1426.full.at:This article cites 7 articles, 1 of which can be accessed free
Citations
html#related-urlshttp://pediatrics.aappublications.org/content/121/5/e1426.full.This article has been cited by 1 HighWire-hosted articles:
Subspecialty Collections
http://pediatrics.aappublications.org/cgi/collection/bloodBloodthe following collection(s):This article, along with others on similar topics, appears in
Permissions & Licensing
mlhttp://pediatrics.aappublications.org/site/misc/Permissions.xhttables) or in its entirety can be found online at:Information about reproducing this article in parts (figures,
Reprintshttp://pediatrics.aappublications.org/site/misc/reprints.xhtml
Information about ordering reprints can be found online:
rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.Grove Village, Illinois, 60007. Copyright 2008 by the American Academy of Pediatrics. Alland trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elkpublication, it has been published continuously since 1948. PEDIATRICS is owned, published,PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
at Pakistan:AAP Sponsored on February 7, 2013pediatrics.aappublications.orgDownloaded from
https://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.htmlhttps://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.htmlhttps://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.htmlhttps://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.html#ref-list-1https://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.html#ref-list-1https://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.html#ref-list-1https://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.html#related-urlshttps://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.html#related-urlshttps://vpn.aku.edu/cgi/collection/,DanaInfo=pediatrics.aappublications.org+bloodhttps://vpn.aku.edu/cgi/collection/,DanaInfo=pediatrics.aappublications.org+bloodhttps://vpn.aku.edu/cgi/collection/,DanaInfo=pediatrics.aappublications.org+bloodhttps://vpn.aku.edu/site/misc/,DanaInfo=pediatrics.aappublications.org+Permissions.xhtmlhttps://vpn.aku.edu/site/misc/,DanaInfo=pediatrics.aappublications.org+Permissions.xhtmlhttps://vpn.aku.edu/site/misc/,DanaInfo=pediatrics.aappublications.org+Permissions.xhtmlhttps://vpn.aku.edu/site/misc/,DanaInfo=pediatrics.aappublications.org+reprints.xhtmlhttps://vpn.aku.edu/site/misc/,DanaInfo=pediatrics.aappublications.org+reprints.xhtmlhttps://vpn.aku.edu/site/misc/,DanaInfo=pediatrics.aappublications.org+reprints.xhtmlhttps://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/,DanaInfo=pediatrics.aappublications.org+https://vpn.aku.edu/site/misc/,DanaInfo=pediatrics.aappublications.org+reprints.xhtmlhttps://vpn.aku.edu/site/misc/,DanaInfo=pediatrics.aappublications.org+Permissions.xhtmlhttps://vpn.aku.edu/cgi/collection/,DanaInfo=pediatrics.aappublications.org+bloodhttps://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.html#related-urlshttps://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.html#ref-list-1https://vpn.aku.edu/content/121/5/,DanaInfo=pediatrics.aappublications.org+e1426.full.html